Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Acq. announced
PHARMACOPEIA INC (PCOP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2009 CT ORDER Form CT ORDER - Confidential treatment order
01/30/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/02/2009 SC 13D AUSTIN JOSIAH T reports a 0% stake in PHARMACOPEIA, INC.
12/30/2008 EFFECT Form EFFECT -- Effectiveness Date: 2008-12-29 Registration Form: POS AM Reference AccNo: 0001104659-08-078272
12/30/2008 EFFECT Form EFFECT -- Effectiveness Date: 2008-12-29 Registration Form: POS AM Reference AccNo: 0001104659-08-078270
12/30/2008 EFFECT Form EFFECT -- Effectiveness Date: 2008-12-29 Registration Form: POS AM Reference AccNo: 0001104659-08-078269
12/24/2008 4 Form 4 - Statement of changes in beneficial ownership of securities
12/24/2008 4 Soeters Martinus Hermanus (Director) has filed a Form 4 on PHARMACOPEIA INC
12/24/2008 4 POSNER BRIAN M (EVP, CFO) has filed a Form 4 on PHARMACOPEIA INC
12/24/2008 4 MOLLICA JOSEPH A (Chairman, Interm-President/CEO) has filed a Form 4 on PHARMACOPEIA INC
12/24/2008 4 Costalas Stephen C (EVP, General Counsel) has filed a Form 4 on PHARMACOPEIA INC
12/24/2008 4 Belder Rene (SVP, Clinical & Regulatory) has filed a Form 4 on PHARMACOPEIA INC
12/24/2008 4 BARTLETT PAUL A (Director) has filed a Form 4 on PHARMACOPEIA INC
12/23/2008 POS AM Form POS AM -- Post-Effective amendments for registration statement
12/23/2008 POS AM Form POS AM -- Post-Effective amendments for registration statement
12/23/2008 POS AM Form POS AM -- Post-Effective amendments for registration statement
12/23/2008 SC TO-I/A Form SC TO-I/A -- Tender offer statement by Issuer [amend]
12/23/2008 8-K Quarterly results
12/23/2008 25-NSE Form 25-NSE --
12/10/2008 SC 13G/A PHARMACOPEIA INC reports a 4.1% stake in PHARMACOPEIA, INC.
12/10/2008 SC 13G/A PHARMACOPEIA INC reports a 1.3% stake in Pharmacopeia Drug Discovery, Inc.
11/12/2008 8-K Form 8-K -- Current report
11/07/2008 8-K Form 8-K -- Current report
11/06/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/06/2008 8-K Quarterly results
Docs: "Pharmacopeia Announces Third Quarter 2008 Financial Results"
11/04/2008 8-K Form 8-K -- Current report
11/03/2008 8-K Investor presentation
Docs: "Presentation Materials"
10/28/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Ligand and Pharmacopeia to Present at the Oppenheimer 19 th Annual Healthcare Conference"
10/14/2008 8-K Other Events
10/03/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Pharmacopeia Receives Notification from NASDAQ"
09/26/2008 8-K Conference call transcript
Docs: "Transcript from Investor Conference Call held on September 24, 2008"
09/25/2008 8-K/A Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger",
"Amendment to Rights Agreement"
09/25/2008 8-K Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T...
Docs: "Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights Acquisition Would Result in Well Capitalized Company with Robust Royalty Assets and Broad Research Pipeline Conference Call Today at 5:30p.m. Eastern",
"Presentation Materials"
09/23/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Second Amended and Restated Severance Agreement, between Pharmacopeia, Inc. and Rene Belder M.D"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy